Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs.
To examine the role of polymorphonuclear neutrophils (PMN) and other granulocytes in the pathogenesis of acute lung injury caused by tumor necrosis factor alpha (TNF), we compared the permeability edema and pulmonary histopathology in normal (granulocyte sufficient) guinea pigs and in granulocytopenic guinea pigs treated with TNF. Circulating granulocytes were depleted with cyclophosphamide. Two groups of normal animals were treated with either saline (PMN+/Control) or 1.4 x 10(6) U/kg recombinant human TNF (PMN+/TNF). Three granulocytopenic groups were treated with either saline (PMN-/Control), TNF (PMN-/TNF), or intravenous infusion of 2 x 10(9) E. coli strain J96 (PMN-/Sepsis). We measured the amount of 125I-labeled albumin in bronchoalveolar lavage (BAL) fluid and whole lung tissue and the wet/dry lung weight ratio to assess pulmonary transvascular protein flux and edema. We also quantified PMN in BAL fluid and fixed lung tissue. There were no statistically significant differences in any of these parameters between the PMN+/Control, PMN-/Control, or PMN-/TNF groups, except that the PMN+/Control predictably had more PMN/alveolus than the PMN- groups. However, both the PMN+/TNF and the PMN-/Sepsis groups had increased amounts of 125I-labeled albumin in BAL fluid and lung tissue (p less than 0.01) and increased wet/dry lung weight ratios (p less than 0.05), compared to all other groups. Histopathologically, capillary congestion and moderate inflammation were seen in the PMN+/TNF group, and acute inflammation and gross alveolar hemorrhage were seen in the PMN-/Sepsis group.(ABSTRACT TRUNCATED AT 250 WORDS)
Stephens
K E
KE
Department of Medicine, Stanford University Medical Center, California 94305-5204.
Ishizaka
A
A
Wu
Z H
ZH
Larrick
J W
JW
Raffin
T A
TA
D000208:Acute Disease; D000380:Agranulocytosis / Q000473:pathology / Q000503:physiopathology*; D000818:Animals; D001834:Body Water / Q000378:metabolism; D001992:Bronchoalveolar Lavage Fluid / Q000473:pathology; D002452:Cell Count; D003520:Cyclophosphamide / Q000494:pharmacology; D004927:Escherichia coli Infections / Q000503:physiopathology; D006168:Guinea Pigs; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008171:Lung Diseases / Q000139:chemically induced / Q000503:physiopathology*; D009504:Neutrophils / Q000473:pathology; D010539:Permeability; D010784:Photomicrography; D011654:Pulmonary Edema / Q000503:physiopathology; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology*
D014409:Tumor Necrosis Factor-alpha; D003520:Cyclophosphamide